Article
Pharmacokinetics of didanosine and drug resistance mutations in infants exposed to zidovudine during gestation or postnatally and treated with didanosine or zidovudine in the first three months of life.
The Pediatric infectious disease journal - 1 Jun 2005
Kovacs Andrea, Cowles Mary Kathryn, Britto Paula, Capparelli Edmund, Fowler Mary Glenn, Moye Jack, McIntosh Ken, Rathore Mobeen H, Pitt Jane, Husson Robert N
Abstract excerpt
BACKGROUND: There are limited numbers of drugs that are available in formulations that are appropriate for neonates and few studies assessing resistance among infants born to human immunodeficiency virus (HIV)-infected women. METHODS: Pharmacokinetics and tolerance of didanosine (ddI) were determined for infants < or =120 days of age. Infants received at least 24 hours of zidovudine (ZDV) treatment, followed by a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
